Dawn M George

USPTO Granted Patents = 11 (Patent Applications = 6)

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 2 (Patent Applications = 6)

Average Co-Inventor Count = 9.3

ph-index = 8

Forward Citations = 356(Granted Patents)

Company Filing History:

Abbott Laboratories Corporation

patents

Years Active: 2011-2019

Loading Chart...

11 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. RE47221 - Tricyclic compounds (2019-02-04),

2. 9365579 - Tricyclic compounds (2016-06-14),

3. 9163007 - 5-substituted indazoles as kinase inhibitors (2015-10-20),

4. 9115151 - Substituted 2,10-dihydro-9-oxa-1,2,4A-triazaphenanthren-3-ones and uses thereof (2015-08-25),

5. 8962629 - Tricyclic compounds (2015-02-24),

6. 8785639 - Substituted dihydropyrazolo[3,4-D]pyrrolo[2,3-B]pyridines and methods of use thereof (2014-07-22),

7. 8754107 - Aminopyrrolidines as chemokine receptor antagonists (2014-06-17),

8. 8648069 - 5-substituted indazoles as kinase inhibitors (2014-02-11),

9. 8598199 - Octahydropentalene compounds as chemokine receptor antagonists (2013-12-03),

10. 8426411 - Tricyclic compounds (2013-04-23),

11. 7939544 - Octahydropentalene compounds as chemokine receptor antagonists (2011-05-10),

Title: The Innovative Journey of Dawn M. George

Introduction

Dawn M. George, an accomplished inventor based in Charlton, MA, has made significant contributions to the field of pharmaceuticals, boasting a remarkable portfolio of 11 patents. Her work primarily focuses on tricyclic compounds that have shown promise in treating various immunological and oncological conditions.

Latest Patents

Dawn's most recent patents involve the development of tricyclic compounds, outlined in two substantial inventions. The first patent presents compounds of Formula (I) and Formula (II), which include pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers, and isomers defined within. These compounds are particularly noteworthy for their application in addressing immunological and oncological disorders. The second patent further specifies a compound of Formula (I) with similar pharmacological adaptability for related medical conditions, reinforcing the therapeutic potential of her innovations.

Career Highlights

Throughout her career, Dawn has contributed her expertise to prominent companies such as AbbVie Inc. and Abbott Laboratories Corporation. Her roles in these leading pharmaceutical firms have allowed her to advance her research and contribute to groundbreaking innovations in medicine.

Collaborations

Dawn has collaborated with talented individuals in her field, including Biqin C. Li and Lu Wang. These partnerships have undoubtedly enriched her research and led to impactful discoveries in pharmaceutical compounds.

Conclusion

Dawn M. George exemplifies the spirit of innovation through her dedication and achievements in pharmaceutical research. With her impressive number of patents and collaborations, she continues to pave the way for advancements in treating complex medical conditions, confirming her position as a notable inventor in her industry.

This text is generated by artificial intelligence and may not be accurate.